2021 Emerging Coagulation Testing Technologies and Strategic Profiles of Leading Suppliers
This 124-page report provides assessments of such technologies as chromogenic substrates, monoclonal and polyclonal antibodies, immunoassays, IT, molecular diagnostics, and their potential applications for coagulation testing.
The report also includes strategic assessments of current and emerging suppliers of coagulation instruments and reagents, products, including marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 124 pages
Monoclonal and Polyclonal Antibodies
Immunoassays
a. Applications
b. Technological Principle
c. Enzyme Immunoassays (EIA)
d. Fluorescent Immunoassays
e. Latex Agglutination
f. Immunoprecipitation
Microcomputers
Automation
Robotics
DNA Probes
Artificial Intelligence
Dry Chemistry
Biosensors
Competitive Assessments
The report provides strategic assessments of over 20
leading coagulation market players and start-up
companies with innovative technologies and
products, including:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago
Grifols
Helena Laboratories
IL/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher, and others
Global Neuromodulation Devices Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast to 2030
The neuromodulation devices market is anticipated to grow at a CAGR of 6.5% over the forecast period of 20202028. According to a study published by Insure Insights on the neuromodulation
USD 3950 View ReportGlobal Neuromarketing Solutions Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast, 2022-2030
The Global Neuromarketing Solutions market is anticipated to rise at a value CAGR of 9.65% over 20202028. According to a study published by Insure Insights on the Global Neuromarketing Solutions
USD 3950 View Report2021 Emerging Clinical Chemistry and Immunodiagnostic Technologies, and Strategic Profiles of Leading Suppliers
This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry chemistry, biosensors, robotics, molecular diagnostics and
USD 2450 View Report2021 Emerging Cancer Diagnostic Technologies and Strategic Profiles of Leading Suppliers
This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing.
USD 2450 View ReportFill The Form For Sample Request